We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601933:SSEYonghui Superstores Co., Ltd. Class A Analysis

Data as of 2026-03-12 - not real-time

CN¥4.06

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Yonghui Superstores is trading at CNY 4.06, barely above the computed support level of 4.02 and well below the resistance of 4.76. Technical indicators are decidedly bearish – the MACD line sits below its signal (bearish) and the 14‑day RSI is at 35.3, suggesting continued downside momentum. Volume trends are weakening, with a "decreasing" volume pattern that often precedes further price erosion, while the 30‑day volatility spikes above 30%, indicating a highly erratic price environment. Fundamental metrics are equally concerning: the company posted a negative operating margin of -5.3%, a loss‑making EBITDA of roughly -2.4 billion CNY, and a staggering debt‑to‑equity ratio of 429, reflecting severe balance‑sheet strain. Valuation multiples are extreme, with a forward P/E of 135× and a price‑to‑book of 9.8× despite negative earnings and cash‑flow, implying the stock is significantly overvalued relative to its financial health.
Given the confluence of weak technical signals, deteriorating profitability, high leverage, and an "Extreme Greed" market sentiment index that may be disconnected from fundamentals, the outlook remains bearish across horizons. The low beta of 0.28 suggests limited market‑wide price swings, but the company's internal volatility and sector exposure to Chinese consumer cycles amplify risk. In the absence of a clear turnaround strategy or dividend cushion, investors should approach Yonghui with heightened caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish MACD and RSI indicating continued downtrend
  • Price near technical support with decreasing volume
  • High short‑term volatility exceeding 30%

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential restructuring to address massive debt load
  • Low beta may limit broader market impact
  • Unclear path to profitability despite current losses

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative earnings and cash‑flow
  • Extreme valuation multiples relative to fundamentals
  • Sector headwinds in Chinese consumer discretionary spending

Key Metrics & Analysis

Financial Health

Revenue Growth-25.50%
Profit Margin-3.78%
P/E Ratio135.3
ROE-49.06%
ROA-4.33%
Debt/Equity429.42
P/B Ratio9.8
Op. Cash FlowCN¥-444577216
Free Cash FlowCN¥-291253376

Technical Analysis

TrendBearish
RSI35.3
SupportCN¥4.02
ResistanceCN¥4.76
MA 20CN¥4.28
MA 50CN¥4.63
MA 200CN¥4.79
MACDBearish
VolumeDecreasing
Fear & Greed Index76.68

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.28
Volatility30.73%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.